liver cell carcinoma
Showing 1 - 8 of 8
Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)
Recruiting
- Liver Cell Carcinoma
- +7 more
- CATCH T cells
- +2 more
-
Houston, TexasHouston Methodist Hospital
Dec 19, 2022
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Nivolumab
- Relatlimab
-
Ciudad de Buenos Aires, Buenos Aires, Argentina
- +74 more
Nov 11, 2022
Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)
Recruiting
- Carcinoma, Hepatocellular
- Liver Cell Carcinoma
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)
Terminated
- Hepatocellular Carcinoma
- +4 more
- Transarterial embolization
- Microwave Ablation
-
Charlotte, North CarolinaCarolinas Medical Center
Apr 20, 2022
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Cell Carcinoma Trial (LioCyx-M, Lenvatinib)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- LioCyx-M
- Lenvatinib
- (no location specified)
Jan 4, 2022
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)
Terminated
- Hepatocellular Carcinoma
- +2 more
- DEB-TACE
- Sorafenib
-
Birmingham, Alabama
- +5 more
Jan 25, 2021
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial (Elbasvir / Grazoprevir Oral Tablet)
Withdrawn
- Hepatocellular Carcinoma
- +3 more
- Elbasvir / Grazoprevir Oral Tablet
- (no location specified)
Sep 6, 2020
Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Los Angeles, Pittsburgh (AFP + GM-CSF Plasmid Prime and AFP
Terminated
- Hepatocellular Carcinoma
- +13 more
- AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost
-
Los Angeles, California
- +1 more
Dec 1, 2015